The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins
- PMID: 2197998
The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins
Abstract
Loss of connective tissue integrity occurs in many disease processes, including rheumatoid arthritis and osteoarthritis. Although there is a high incidence of these diseases in the developed world, there is no treatment that prevents the tissue damage that occurs. Several lines of evidence suggest that uncontrolled connective tissue metalloproteinase activity is responsible for the damage, and as a consequence the inhibition of these enzymes has become the target for therapeutic intervention. Several connective tissue metalloproteinases, including collagenase, stromelysin, and gelatinase, together with tissue inhibitors of metalloproteinases (TIMPs), have been described. Because of difficulties in isolating the metalloproteinases in sufficient quantity as pure separate enzymes, however, very little knowledge has accumulated about their detailed biochemistry. For similar reasons the way in which TIMPs inhibit tissue metalloproteinases is not yet fully understood. In this article it is shown how cloning metalloproteinase and TIMP cDNAs can provide information about the structure of these enzyme and inhibitor families and how the cDNAs can be used to generate recombinant cell lines from which enzymes and inhibitors can be readily purified for further studies.
Similar articles
-
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.Cancer Res. 2001 May 1;61(9):3610-8. Cancer Res. 2001. PMID: 11325829
-
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.J Cell Physiol. 1993 Aug;156(2):235-46. doi: 10.1002/jcp.1041560204. J Cell Physiol. 1993. PMID: 8344982
-
Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).Exp Hematol. 1995 Feb;23(2):155-60. Exp Hematol. 1995. PMID: 7828672
-
The regulation of connective tissue metalloproteinases by natural inhibitors.Agents Actions Suppl. 1991;35:69-76. Agents Actions Suppl. 1991. PMID: 1781423 Review.
-
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.Eur J Cell Biol. 1997 Oct;74(2):111-22. Eur J Cell Biol. 1997. PMID: 9352216 Review.
Cited by
-
Structural aspects of the metzincin clan of metalloendopeptidases.Mol Biotechnol. 2003 Jun;24(2):157-202. doi: 10.1385/MB:24:2:157. Mol Biotechnol. 2003. PMID: 12746556 Review.
-
Sequencing and characterization of the soybean leaf metalloproteinase : structural and functional similarity to the matrix metalloproteinase family.Plant Physiol. 1992 Jul;99(3):1179-83. doi: 10.1104/pp.99.3.1179. Plant Physiol. 1992. PMID: 16668986 Free PMC article.
-
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.J Clin Invest. 2001 May;107(9):1117-26. doi: 10.1172/JCI10403. J Clin Invest. 2001. PMID: 11342575 Free PMC article.
-
Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.Biochem J. 1993 Dec 15;296 ( Pt 3)(Pt 3):803-9. doi: 10.1042/bj2960803. Biochem J. 1993. PMID: 8280080 Free PMC article.
-
Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).Biochem J. 1991 Jul 1;277 ( Pt 1)(Pt 1):277-9. doi: 10.1042/bj2770277. Biochem J. 1991. PMID: 1649600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous